← Browse by Condition
Medical Condition
psoriasis
Total Trials
14
Recruiting Now
14
Trial Phases
Phase 4, Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for psoriasis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — psoriasis Clinical Trials
How many clinical trials are currently recruiting for psoriasis?
ClinicalMetric currently tracks 14 actively recruiting clinical trials for psoriasis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for psoriasis?
psoriasis research spans Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (5 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a psoriasis clinical trial?
Eligibility criteria for psoriasis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 3 1
Phase 4 5
Top Sponsors
3 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04372277 Phase 4
Recruiting
Enrollment
25 pts
Location
United States
Sponsor
Psoriasis Treatment Center of ...
NCT04119102 Phase 4
Recruiting
Enrollment
25 pts
Location
United States
Sponsor
Psoriasis Treatment Center of ...
NCT06989216
Recruiting
Enrollment
8,000 pts
Location
Sweden
Sponsor
HJN Sverige AB/Neko Health
NCT07432815 Phase 4
Recruiting
Enrollment
40 pts
Location
Egypt
Sponsor
Cairo University
NCT06574178
Recruiting
Enrollment
5 pts
Location
United States
Sponsor
University of California, Davi...
NCT06735911
Recruiting
Enrollment
70 pts
Location
France
Sponsor
Thermes de Bareges
NCT04864886
Recruiting
Enrollment
300 pts
Location
United States
Sponsor
National Institute of Allergy ...
NCT04347473 Phase 4
Recruiting
Enrollment
25 pts
Location
United States
Sponsor
Psoriasis Treatment Center of ...
NCT07719530 Phase 2
Recruiting
Enrollment
60 pts
Location
China
Sponsor
Guangdong Hengrui Pharmaceutic...
NCT07265284 Phase 3
Recruiting
Enrollment
104 pts
Location
China
Sponsor
Innovent Biopharmaceutical Tec...
NCT07615257
Recruiting
Enrollment
128 pts
Location
Pakistan
Sponsor
Islamia University of Bahawalp...
NCT06857942 Phase 4
Recruiting
Enrollment
200 pts
Location
United States
Sponsor
Eli Lilly and Company
NCT07532486
Recruiting
Enrollment
400 pts
Location
China
Sponsor
Second Affiliated Hospital, Zh...
NCT05122039
Recruiting
Enrollment
200 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology